Results 21 to 30 of about 77,075 (344)

Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions

Clinics, 2014
OBJECTIVES: Our previous study demonstrated that superoxide dismutase levels were higher in tuberculous pleural effusions than in malignant pleural effusions, but that this difference ...
Maoshui Wang, Zhiqiang Zhang, Xinfeng Wang   +2 more
doaj   +1 more source

Different Therapeutic Strategies in 2 Young Patients with Advanced ALK-Rearranged Lung Adenocarcinoma: “The Light at the End of the Tunnel”

Case Reports in Oncology, 2021
Malignant pleural effusion represents a prognostic negative factor on survival conferring stage IV disease. The median of survival is 5 months and a 5-year survival of about 3%.
Umberto Caterino, Cristiano Cesaro, Enzo Zamparelli, Flavio Cesaro, Alba Palma, Raffaella Lucci, Pasquale Imitazione, Dino Casazza, Dario Amore   +8 more
doaj   +1 more source

Bacterial Infection Elicits Heat Shock Protein 72 Release from Pleural Mesothelial Cells [PDF]

, 2013
Heat shock protein 70 (HSP70) has been implicated in infection-related processes and has been found in body fluids during infection. This study aimed to determine whether pleural mesothelial cells release HSP70 in response to bacterial infection in vitro
Bielsa, S, Brown, JS, Creaney, J, della Vergiliana, JFV, Lansley, SM, Lee, YCG, Porcel, JM, Temple, SEL, Waterer, GW   +8 more
core   +1 more source

Value of Detection of CAIX in the Pleural Effusion and Its Sediment in the Diagnosis of Lung Cancer

Chinese Journal of Lung Cancer, 2015
Background and objective Carbonic anhydrase IX (CAIX) is widely expressed in a variety of malignant tumors, including-lung cancer. Our previous study has shown that the serum level of soluble form of carbonic anhydrase IX (s-CAIX) was significantly ...
Lina PENG, Xiao’e WANG, Diansheng ZHONG, Qian WANG, Chang LIU   +4 more
doaj   +1 more source

The role of tumor necrosis factor alpha in differentiation between malignant and non malignant pleural effusion

Egyptian Journal of Chest Disease and Tuberculosis, 2016
Background: Despite the fact that Light’s criteria remain the gold standard approach in differentiating exudates from transudates, several fluid markers have been introduced for establishing the cause of pleural effusion to differentiate types of pleural
Heba M. Atef, Ali A. Okab, Gehan F. Al mehy, Mona M. El Beheisy   +3 more
doaj   +1 more source

Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer [PDF]

, 2004
Background Advanced ovarian cancer is the leading non-breast gynaecologic cause of malignant pleural effusion. Aim of this study was to assess the efficacy of mitoxantrone sclerotherapy as a palliative treatment of malignant pleural effusions due to ...
FH Hausheer, TJ Lynch, L Saffran, PM Dvoretsky, SA Sahn, WW Johnston, G Antunes, FH Hausheer, E Patz, KG Seaton, D Cheng, DL Hartman, TR Gravelyn, BA Goff, MJ Moffet, MJ Ostrowski, JC Ruckdeschel, DH Rehse, EM Marom, BL Fingar, FS Vargas, D Seitzer, E Musch, AG Maiche, AF Van Belle, M Morales, G Groth   +26 more
core   +2 more sources

Protocol of the Australasian Malignant Pleural Effusion (AMPLE) trial: a multicentre randomised study comparing indwelling pleural catheter versus talc pleurodesis [PDF]

, 2014
INTRODUCTION: Malignant pleural effusion can complicate most cancers. It causes breathlessness and requires hospitalisation for invasive pleural drainages. Malignant effusions often herald advanced cancers and limited prognosis.
Bint, M, Fysh, ETH, Garske, LA, Horwood, FC, Lam, BCH, Lam, CLD, Lee, P, Lee, YCG, Murray, K, Piccolo, F, Read, CA, Rosenstengel, A, Shrestha, R, Smith, NA, Thomas, R, Yap, E   +15 more
core   +1 more source

Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. The alteplase dose assessment for Pleural infection Therapy project [PDF]

, 2017
Rationale: Intrapleural therapy with a combination of tissue plasminogen activator (tPA) 10 mg and DNase 5 mg administered twice daily has been shown in randomized and open-label studies to successfully manage over 90% of patients with pleural infection ...
Bintcliffe, Oliver, Blyth, Kevin G., De Fonseka, Duneesha, Edey, Anthony, Lee, Y. C. Gary, Martin, Geoffrey, Maskell, Nick, Piccolo, Francesco, Popowicz, Natalia, Smith, Nicola A., Wong, Donny   +10 more
core   +1 more source

Lumican is overexpressed in lung adenocarcinoma pleural effusions. [PDF]

, 2015
Adenocarcinoma (AdC) is the most common lung cancer subtype and is often associated with pleural effusion (PE). Its poor prognosis is attributable to diagnostic delay and lack of effective treatments and there is a pressing need in discovering new ...
Arrigoni, Giorgio, Cappellesso, Rocco, Caroccia, Brasilina, Fassina, Ambrogio, Guzzardo, Vincenza, Iori, Elisabetta, Millioni, Renato, Simonato, Francesca, Tessari, Paolo, Ventura, Laura   +9 more
core   +9 more sources

Diagnostic Values of Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptor for Benign and Malignant Hydrothorax

Chinese Medical Journal, 2015
Background: Hydrothorax, as one of the common complications of malignant tumors, still cannot be sensitively detected in clinical practice, thus requiring a sensitive, specific method for diagnosis.
Yan Gu, Min Zhang, Guo-Hua Li, Jun-Zhen Gao, Liping Guo, Xiao-Juan Qiao, Li-Hong Wang, Lan He, Mei-Ling Wang, Li Yan, Xiu-Hua Fu   +10 more
doaj   +1 more source